Jason Andrew Rifkin

CIK 1462850 · View on SEC EDGAR ↗

Insider

First SEC filing: May 1, 2009 · Latest: May 1, 2009

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 1 non-open-market transaction below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Oct. 12, 2009 DCTH A 75,000 75,000 Direct Acquired (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Oct. 12, 2009 DCTH Stock Option (right to buy) Common Stock (75,000) $5.46 Oct. 12, 2019 75,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 5 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
May 1, 2009 DCTH Common Stock, par value $0.01 1,135 Direct
May 1, 2009 DCTH Stock Option→ Common Stock, par value $0.01 (50,000) 50,000 Direct
May 1, 2009 DCTH Stock Option→ Common Stock, par value $0.01 (20,000) 20,000 Direct
May 1, 2009 DCTH Stock Option→ Common Stock, par value $0.01 (20,000) 20,000 Direct
May 1, 2009 DCTH Stock Option→ Common Stock, par value $0.01 (25,000) 25,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

DCTH

President Clinical Operations and Secretary(4)
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2008 $150,000 $20,204 $170,204

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.